Mutation identified in aplastic anemia that shortens telomeres on ends of chromosomes
9/25/2014
An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells.
Keeping 'jumping genes' in check could help control some age-related diseases
9/25/2014
Most organisms, including humans, have parasitic DNA fragments called "jumping genes" that insert themselves into DNA molecules, disrupting genetic instructions in the process.
Genetic driver of inflammation uncovered, used to prevent and treat liver cancer
9/25/2014
Inflammation has been shown to be a driving force behind many chronic diseases, especially liver cancer, which often develops due to chronic inflammation caused by conditions such as viral hepatitis...
Researchers from the University of Toronto, directed by Drs. Gelareh Zadeh and Boris Krischek, investigated gene expression in normal vestibular nerves and vestibular schwannomas (VSs).
'Increased risk of venous thromboembolism among NSAID users'
9/25/2014
Venous thromboembolism - the condition that includes both deep vein thrombosis and pulmonary embolism - has been linked to NSAID use in a new systematic review and meta-analysis.
UK-based chemists report 'designer proteins' breakthrough
9/24/2014
A team from the University of Leicester claims to have developed a new process for synthesizing amino acids, which may form the basis of new drugs to treat cancer and Alzheimer's.
Gene discovered that increases incidence of acute myelogenous leukaemia
9/24/2014
A novel study by the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) found that an increase in a gene known as Leo1 affects other genes that are...
TCD announces successful completion of its TCD-717 Phase I trial
9/24/2014
Traslational Cancer Drugs Pharma, S.L. has announced in BioSpain that their Phase I study performed in patients with advanced solid tumors with TCD-717 has been successfully completed.
New approach aims to silence cancer 'survival genes'
9/24/2014
Scientists at the University of York are working on a promising new approach for tackling colorectal cancer, the second most common cause of cancer-related death.
The European Head and Neck Society (EHNS) and the European Cancer Patient Coalition (ECPC) reconvened in the European Parliament to call for the implementation of a Europe-wide head and neck...